Experiences of key populations in multidrug-resistant TB and HIV

Hlengiwe Nyilana, Karl Reis, Boitumelo Seepamore, Rubeshan Perumal, Allison Wolf, Karen Guzmán, K. Rivet Amico, Mbawe Zulu, Senzo Hlathi, Xuan Lu, T. Mabuyi, N. Nhlangulela, Régis Perrier, Matthew E. Wilson, Gerald Friedland, Kogieleum Naidoo, Amrita Daftary, Jennifer Zelnick, Martin O’DonnellThe International Journal of Tuberculosis and Lung Disease 2025 · DOI

Abstract

Key populations for multidrug-resistant TB (MDR-TB) face heightened vulnerability due to social, behavioral, and structural barriers, such as poverty, substance use and stigma. Here we illustrate the difficulties faced with a composite personal narrative based on the experiences of two participants in a clinical trial of adherence support interventions for people with MDR-TB and HIV. Addressing these factors through tailored interventions is crucial to improving care engagement and challenging one-size-fits-all approaches to TB prevention.
BibTeX
@article{nyilana2025experiences,
  author = {Hlengiwe Nyilana and Karl Reis and Boitumelo Seepamore and Rubeshan Perumal and Allison Wolf and Karen Guzmán and K. Rivet Amico and Mbawe Zulu and Senzo Hlathi and Xuan Lu and T. Mabuyi and N. Nhlangulela and Régis Perrier and Matthew E. Wilson and Gerald Friedland and Kogieleum Naidoo and Amrita Daftary and Jennifer Zelnick and Martin O’Donnell},
  title = {{Experiences of key populations in multidrug-resistant TB and HIV}},
  journal = {The International Journal of Tuberculosis and Lung Disease},
  year = {2025},
  doi = {10.5588/ijtld.25.0094},
}

Loading related content...

Figure